Search results
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 days agoCOLL renegotiated a major Medicare Part D contract for Belbuca, maintaining its access position and...
Big Changes Coming to Medicare in 2025: What You Need to Know
TheStreet.com· 7 days agoIt may be months before the calendar flips to 2025, but not for Medicare. The Centers for Medicare & Medicaid Services (CMS), which runs the program, just announced two major changes for 2025 ...
Navigating Vaccine Coverage for Seniors With Medicare Changes | ThinkAdvisor
ThinkAdvisor· 6 days agoThe COVID vaccine is just one of many that clients might want.
Novo Nordisk earnings are coming during a weight loss drugs sales surge. Here are 3 things to watch
Quartz· 1 day agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy,...
'Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse
The Day· 6 hours agoThe American Heart Association calls them "game changers." Oprah Winfrey says they're "a gift." Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. Obesity ...
Medigap Policies Face New Federal Nondiscrimination Rule | ThinkAdvisor
ThinkAdvisor· 3 days agoThe U.S. Department of Health and Human Services is changing its strategy for regulating Medicare...
CVS reports $1.1B income in Q1, cuts earnings guidance
Becker’s Hospital Review· 1 day agoCVS Health cut its earnings guidance for 2024 based on rising medical costs. CVS Health reported $1.1 billion in net income in the first quarter of 2024, according to its latest earnings documents ...
Mirae Asset Global Investments Co. Ltd. Has $630,000 Stake in eHealth, Inc. (NASDAQ:EHTH)
ETF DAILY NEWS· 6 days agoMirae Asset Global Investments Co. Ltd. lifted its stake in shares of eHealth, Inc. (NASDAQ:EHTH – Free Report) by 101.8% in the 4th quarter, according to the company in its most recent filing ...
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...
Benzinga· 2 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 3 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
